Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Disruption in glutathione metabolism and altered energy production in the liver and kidney after ischemic acute kidney injury in mice Scientific Reports Glutathione specific gammaglutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis Science Translational Medicine Oxidative Stress in Non Dialysis Dependent Chronic Kidney Disease Patients Kidney injury detection with biomarkers and the NIR II Photon etc. Most kidney patients are focused on creatinine while almost nobody is talking about what's happening inside the kidney cells. That's where NAC and ALA become interesting. Because kidney disease is not just